Chromosome 10q deletion syndrome is a rare genetic disorder caused by the loss (deletion) of a segment of the long arm (q arm) of chromosome 10 (see Rareshare Guide on Chromosomal Nomenclature). The clinical presentation varies widely depending on the size and exact location of the deleted segment, as different genes may be affected. Individuals commonly have developmental delays, intellectual disability, growth abnormalities leading to distinct facial features, and multiple abnormalities present from birth. The condition is considered a contiguous gene deletion syndrome, meaning that loss of several neighboring genes contributes to the range of clinical features.
A more common subset of this rare condition is chromosome 10q26 deletion, or distal monosomy 10q. This deletion occurs at the specific site 10q26 and often presents with developmental delays, motor delays, and a delay in speech or lack of speech development.
Chromosome 10q deletion syndrome is a rare genetic disorder caused by the loss (deletion) of a segment of the long arm (q arm) of chromosome 10 (see Rareshare Guide on Chromosomal Nomenclature). The clinical presentation varies widely depending on the size and exact location of the deleted segment, as different genes may be affected. Individuals commonly have developmental delays, intellectual disability, growth abnormalities leading to distinct facial features, and multiple abnormalities present from birth. The condition is considered a contiguous gene deletion syndrome, meaning that loss of several neighboring genes contributes to the range of clinical features.
A more common subset of this rare condition is chromosome 10q26 deletion, or distal monosomy 10q. This deletion occurs at the specific site 10q26 and often presents with developmental delays, motor delays, and a delay in speech or lack of speech development.
Chromosome 10q deletion syndrome is very rare, and its exact prevalence is unknown. Only a limited number of cases have been reported in the medical literature. Only about 100 cases of chromosome 10q26 deletion syndrome specifically have been recorded. Because clinical features vary widely and genetic testing is required for confirmation, some cases may go undiagnosed or misdiagnosed, making accurate population estimates difficult.
| Name | Abbreviation |
|---|---|
| 10q deletion syndrome | |
| Deletion of the long arm of chromosome 10 | |
| Distal 10q deletion syndrome | 10q26 |
| Proximal 10q deletion syndrome |
The condition results from a partial deletion of chromosome 10q, which leads to loss of multiple genes important for normal development. The deletion may occur de novo (spontaneously in the affected individual) or be inherited from a parent with a chromosomal rearrangement in an autosomal dominant pattern (see Rareshare Guide on Genetic Inheritance). When the mutation arises in an offspring without being present in either parent, it is usually the result of spontaneous mutations occurring during the development of reproductive cells during a parents’ lifetime. The specific features of the syndrome depend on which genes are missing and how large the deleted segment is.
In chromosome 10q26 deletion syndrome specifically, individuals are missing between 3.5 million and 17 million DNA building blocks (base pairs) in various regions in this section of the chromosome.
Clinical manifestations vary but commonly include developmental and physical abnormalities. Frequently reported physical features include:
Distinctive facial features:
Broad nasal bridge
Widely spaced eyes
Low-set ears
Thin upper lip
Small jaw
Small head size
Prominent or beaked nose
Short neck with an appearance of excess skin (webbed neck)
Other symptoms that can result from this rare condition:
Developmental delay and intellectual disability (ranging from mild to severe) - can include attention deficit/hyperactivity disorder (ADHD)
Hypotonia - low muscle tone
Growth delay or short stature
Congenital heart defects (present from birth)
Genitourinary anomalies - abnormal development of the genitals, more common in children born genetically male with this condition
Skeletal abnormalities such as curvature of the spine (scoliosis), limited elbow or other joint movement, clinodactyly of fifth fingers/toes
Feeding difficulties in infancy
Behavioral differences or learning disabilities
Delays in speech or lack of speech development
Some individuals may also have seizures, vision or hearing problems, or immune system abnormalities depending on the genes affected, but these symptoms are less common.
Diagnosis is suspected based on developmental delay and congenital anomalies, especially when multiple organ systems are involved. Because clinical features are variable and often nonspecific, confirmation requires genetic testing to identify the chromosomal deletion.
Chromosomal microarray analysis (CMA): The most commonly used test to detect chromosomal deletions, their location, and determine their size
Karyotype analysis: May identify larger deletions or structural chromosomal abnormalities
Fluorescence in situ hybridization (FISH): Can confirm a suspected deletion in a specific region; requires suspicion of certain chromosomal region to investigate
Parental chromosome studies: Used to determine whether the deletion is inherited or de novo
Additional evaluations (e.g., echocardiogram, renal ultrasound, developmental assessment) may be performed to identify associated medical issues.
There is no cure for chromosome 10q deletion syndrome, and treatment focuses on supportive and symptom-based management. Care is typically multidisciplinary and may include:
Early intervention programs (speech, occupational, and physical therapy)
Educational support and individualized learning plans
Medical management of congenital heart defects or other structural anomalies
Nutritional and feeding support when needed
Treatment for seizures or other neurologic issues
Ongoing monitoring for developmental and medical complications
The prognosis varies widely depending on the size and location of the deletion and the severity of associated medical problems. Some individuals have mild developmental delays and relatively few medical complications, while others have significant intellectual disability and complex health needs. With appropriate medical care, early intervention, and supportive therapies, many individuals can achieve meaningful developmental progress and improved quality of life, though long-term outcomes are highly individualized.
Hello, I am a therapist working with a 4-year-old girl in Philadelphia, PA, USA, who has this deletion -- 10 q 21 of 12 Mb, or 10 q 21.1q 22.1. Her moderate hearing loss and moderate vision loss are being addressed now, and her Physical Therapy and I think Occupational Therapy is happening. She had been viewed as having autistic characteristics, but she has been making such great progress -- attending preschool, having a structured predictable setting, and hearing and seeing better with her hearing aids and glasses -- that I question the view that she is on the (autism) spectrum, but time may tell. If you have any experience with this deletion, please write on this discussion forum. I would be very interested in learning from you. If you have *any experience with any chromosomal deletion* and can offer a family some printed or spoken resources *in MANDARIN*, that would be very much appreciated. Thank you!!! Su (QueegQueeg)
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.
Enrolling is easy.
After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.
Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.
Visit sanfordresearch.org/CoRDS to enroll.
Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.
Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.
Created by QueegQueeg | Last updated 24 Jan 2012, 02:48 AM
Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.
FIND YOUR COMMUNITY
Our rare disease resources include e-books and podcasts
Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.